Naftali Kaminski, MD
Dr. Kaminski has a long time commitment to studying the basic molecular networks that underlie the lung phenotype in pulmonary fibrosis. He has pioneered the application of microarray technology to lung fibrosis and has applied this technology in a variety of models and disease states. Dr. Kaminski has also been actively involved in developing bioinformatic and computational approaches to data analysis and implementing “Systems Biology Approaches” in pulmonary medicine. Dr Kaminski’s research is funded by the NIH and is currently focused on identifying new markers to improve diagnosis and outcome of IPF and on developing new therapeutic targets in the disease. Dr. Kaminski has authored more than 75 papers, reviews and book chapters. Dr Kaminski is active on the American Thoracic Society and was the editor of “Gene Express”, a column on genomics at the American Thoracic Society Website as well as a member and chair of the International Program Committee of the Assembly on Respiratory Cell and Molecular Biology at the American Thoracic Society. To read more on Dr Kaminski’s research click here. Meet
Dr. Kaminski Video requires the latest version of RealPlayer, download RealPlayer Basic (free version available). |
Website Terms of Use
|
E-mail Terms of Use |
Medical Advice Disclaimer |
UPMC |
HOME
About
Us
Diseases
We Treat
Your
First Visit
Our
Staff
Directions
Academic
Resources
Contact
Us
Donations
